Acura Pharmaceuticals Secures $10.0M of Debt Financing

Acura Pharmaceuticals, (NASDAQ: ACUR ) entered into a Loan and Security Agreement (the "Loan Agreement") with Oxford Finance LLC, pursuant to which Oxford agreed to make a term loan to the Company in the principal amount of $10.0 million. The loan has a fixed interest rate of 8.35% per annum with interest only